GSC
PTX

Ground Swell Capital’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Ground Swell Capital’s Portfolio PTX Stock Details PTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$1K Sell
9
-608
-99% -$47.9K ﹤0.01% 2308
2014
Q2 		$55K Buy
+617
New +$37.8K 0.11% 125

Other funds holding PTX

JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
KIA
Kopp Investment Advisors Bloomington, Minnesota $54.4M AUM 14.33% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Ground Swell Capital's PTX Position: Q3 2014 in Review

Ground Swell Capital reduced its Pernix Therapeutics Holdings, Inc. (PTX) stake by 99% in Q3 2014, selling an estimated $47.9K and leaving 9 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #2308.

Ground Swell Capital first reported a position in PTX in Q2 2014 and has held it in 2 quarters since. The position peaked at $55K in Q2 2014. 83 funds tracked by Wall St. Rank hold PTX as of Q3 2014.

  • Ground Swell Capital held 9 shares of Pernix Therapeutics Holdings, Inc. worth $1K as of Q3 2014.
  • Ground Swell Capital sold 608 Pernix Therapeutics Holdings, Inc. shares in Q3 2014, an estimated $47.9K.
  • Pernix Therapeutics Holdings, Inc. made up ﹤0.01% of Ground Swell Capital's portfolio in Q3 2014, its #2308 holding.
  • Ground Swell Capital first reported a position in Pernix Therapeutics Holdings, Inc. in Q2 2014 and has held it in 2 quarters since.
  • Ground Swell Capital's Pernix Therapeutics Holdings, Inc. position peaked at $55K in Q2 2014.
  • 83 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q3 2014.

Based on Ground Swell Capital's 13F filing for Q3 2014, filed 6 Nov 2014.